41P Phase I Analysis of Ubamatamab (muc16xcd3 Bispecific Antibody) in Patients with Recurrent Ovarian CancerK.N. Moore,D. O'Malley,E. Van Nieuwenhuysen, E. Hamilton,R.E. O'Cearbhaill,O. Yeku,S. Bouberhan, J.Y. Hou,M. Peterman,P. Goncalves,T. Schmidt,S-Y. Yoo, M. Zhu,I. Lowy, T. Rowlands,T. Uldrick,E.A. Miller, J. LiuESMO open(2023)引用 0|浏览24暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要